Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

1.

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Chia D, Crawford ED, Kaaks R, Hayes RB.

Int J Cancer. 2007 Nov 15;121(10):2267-73.

PMID:
17597108
[PubMed - indexed for MEDLINE]
2.

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.

PMID:
11106682
[PubMed - indexed for MEDLINE]
Free Article
3.

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.

PMID:
11352850
[PubMed - indexed for MEDLINE]
Free Article
4.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

PMID:
12873996
[PubMed - indexed for MEDLINE]
Free Article
5.

Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.

Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.

PMID:
16775172
[PubMed - indexed for MEDLINE]
Free Article
6.

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ.

J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.

PMID:
10203281
[PubMed - indexed for MEDLINE]
Free Article
7.

Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.

Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1413-8.

PMID:
12433720
[PubMed - indexed for MEDLINE]
Free Article
8.

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E.

J Natl Cancer Inst. 2002 Jul 17;94(14):1099-106.

PMID:
12122101
[PubMed - indexed for MEDLINE]
Free Article
9.

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.

Wolk A, Mantzoros CS, Andersson SO, Bergström R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D.

J Natl Cancer Inst. 1998 Jun 17;90(12):911-5.

PMID:
9637140
[PubMed - indexed for MEDLINE]
Free Article
10.

Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.

Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ.

J Natl Cancer Inst. 2001 Sep 5;93(17):1330-6.

PMID:
11535708
[PubMed - indexed for MEDLINE]
Free Article
11.

Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.

Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.

Gastroenterology. 2005 Aug;129(2):464-75.

PMID:
16083703
[PubMed - indexed for MEDLINE]
12.

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.

Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R.

J Clin Oncol. 2004 Aug 1;22(15):3104-12.

PMID:
15284261
[PubMed - indexed for MEDLINE]
Free Article
13.

Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.

Schairer C, McCarty CA, Isaacs C, Sue LY, Pollak MN, Berg CD, Ziegler RG.

Horm Cancer. 2010 Apr;1(2):100-11. doi: 10.1007/s12672-010-0013-y.

PMID:
21761353
[PubMed - indexed for MEDLINE]
14.

Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.

Lin Y, Tamakoshi A, Kikuchi S, Yagyu K, Obata Y, Ishibashi T, Kawamura T, Inaba Y, Kurosawa M, Motohashi Y, Ohno Y.

Int J Cancer. 2004 Jul 1;110(4):584-8.

PMID:
15122592
[PubMed - indexed for MEDLINE]
15.

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.

Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.

Cancer. 2005 Jan 1;103(1):76-84.

PMID:
15540247
[PubMed - indexed for MEDLINE]
Free Article
16.

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.

Mikami K, Ozasa K, Nakao M, Miki T, Hayashi K, Watanabe Y, Mori M, Sakauchi F, Washio M, Kubo T, Suzuki K, Wakai K, Nakachi K, Tajima K, Ito Y, Inaba Y, Tamakoshi A; JACC Study Group.

Asian Pac J Cancer Prev. 2009 Dec;10 Suppl:57-61.

PMID:
20553083
[PubMed - indexed for MEDLINE]
Free Article
17.

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study.

Oliver SE, Gunnell D, Donovan J, Peters TJ, Persad R, Gillatt D, Pearce A, Neal DE, Hamdy FC, Holly J.

Int J Cancer. 2004 Mar 1;108(6):887-92.

PMID:
14712493
[PubMed - indexed for MEDLINE]
18.

Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.

Chen C, Freeman R, Voigt LF, Fitzpatrick A, Plymate SR, Weiss NS.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2461-6.

PMID:
17164371
[PubMed - indexed for MEDLINE]
Free Article
19.

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.

Sarma AV, Jaffe CA, Schottenfeld D, Dunn R, Montie JE, Cooney KA, Wei JT.

Urology. 2002 Mar;59(3):362-7.

PMID:
11880071
[PubMed - indexed for MEDLINE]
20.

Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).

Li L, Yu H, Schumacher F, Casey G, Witte JS.

Cancer Causes Control. 2003 Oct;14(8):721-6.

PMID:
14674736
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk